First Tracks Biotherapeutics, Inc.
TRAXNasdaqCIK 2091349HealthcareFiscal year ends Dec 31
Reports and events: 12 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2607:37 ET | S-1 | Registration statement | 0001193125-26-431033 |
| 2026-10-2016:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-426666 |
| 2026-10-1516:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422929 |
| 2026-10-1308:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-419761 |
| 2026-08-1216:24 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-346931 |
| 2026-08-1216:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346908 |
| 2026-06-2216:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-277504 |
| 2026-05-1416:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224190 |
| 2026-05-1416:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224124 |
| 2026-05-0816:37 ET | S-1 | Registration statement | 0001193125-26-214778 |
| 2026-04-2017:23 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164328 |
| 2026-04-0319:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-140835 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 06:15 ET. Listed shows no prices and gives no investment advice.